These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 514558)

  • 21. Preferential transfer of endogenous ovarian steroid hormones to the uterus during both the follicular and luteal phases.
    Cicinelli E; Einer-Jensen N; Cignarelli M; Mangiacotti L; Luisi D; Schonauer S
    Hum Reprod; 2004 Sep; 19(9):2001-4. PubMed ID: 15243001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of reported prostaglandin synthetase inhibitors on estradiol-stimulated uterine prostaglandin biosynthesis in vivo in the ovariectomized rat.
    Jordan VC; Castracane VD
    Prostaglandins; 1976 Dec; 12(6):1073-81. PubMed ID: 1005739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer.
    Read GF; Bradley JA; Wilson DW; George WD; Griffiths K
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):9-17. PubMed ID: 4038658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of plasma estradiol, progesterone and benign breast disease].
    Huang PH
    Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):644-5, 700. PubMed ID: 3254791
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostaglandin E2 and cyclic AMP levels in human breast tumors.
    Feller N; Malachi T; Halbrecht I
    J Cancer Res Clin Oncol; 1979 Apr; 93(3):275-80. PubMed ID: 224064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients.
    Malachi T; Chaimoff C; Feller N; Halbrecht I
    J Cancer Res Clin Oncol; 1981; 102(1):71-9. PubMed ID: 6277959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Aspirin, prostaglandins, and the gut.
    Lancet; 1975 Nov; 2(7942):961-2. PubMed ID: 53439
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of local progesterone on benign breast diseases. 500 case studies].
    Lafaye C; Aubert B
    J Gynecol Obstet Biol Reprod (Paris); 1978 Sep; 7(6):1123-39. PubMed ID: 730990
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevated plasma prostaglandin E2 levels in schizophrenia.
    Kaiya H; Uematsu M; Ofuji M; Nishida A; Takeuchi K; Nozaki M; Idaka E
    J Neural Transm; 1989; 77(1):39-46. PubMed ID: 2746199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical approach to women with severe mastalgia and the therapeutic possibilities.
    Blichert-Toft M; Watt-Boolsen S
    Acta Obstet Gynecol Scand Suppl; 1984; 123():185-8. PubMed ID: 6594010
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke.
    Carasso RL; Vardi J; Rabay JM; Zor U; Streifler M
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):967-9. PubMed ID: 591974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A theoretical model of biochemical control engineering based on the relation between oestrogens/progestagens and prostaglandins.
    van der Veen PH
    Med Hypotheses; 2015 Jun; 84(6):557-69. PubMed ID: 25796093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-keto-13,14-dihydroprostaglandin E2 concentrations in serum of patients with breast cancer.
    Powles TJ; Coombes RC; Neville AM; Ford HT; Gazet JC; Levine L
    Lancet; 1977 Jul; 2(8029):138. PubMed ID: 69217
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac output and gonadal steroids.
    Loucks AB
    Fertil Steril; 1984 Nov; 42(5):810-1. PubMed ID: 6489551
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nor-steroids in functional mastopathies].
    RIUSECH G
    Sem Med; 1961 Jul; 119():87-9. PubMed ID: 13741922
    [No Abstract]   [Full Text] [Related]  

  • 36. [Functional mastopathies].
    TORRES MARTINEZ H
    Ginecol Obstet Mex; 1961; 16():383-99. PubMed ID: 14039767
    [No Abstract]   [Full Text] [Related]  

  • 37. [Considerations on functional mastopathies].
    LABANDIBAR B
    Rev Medica Hosp Esp; 1955; 25(7-9):78-82. PubMed ID: 13298233
    [No Abstract]   [Full Text] [Related]  

  • 38. [About mastopathies].
    GENTIL F
    Arq Patol; 1954 Dec; 26(3):351-80. PubMed ID: 13315000
    [No Abstract]   [Full Text] [Related]  

  • 39. [Commentary on the report: "Functional mastopathies"].
    VIESCA E; SANCHEZ SILLER C; DE LARA S
    Ginecol Obstet Mex; 1961; 16():399-404. PubMed ID: 13925854
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology and endocrinology of benign breast disease.
    Wang DY; Fentiman IS
    Breast Cancer Res Treat; 1985; 6(1):5-36. PubMed ID: 3902125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.